Syngenta CEO: ‘No formal decision has been made on a potential IPO’
This content was published on
Jeff Rowe, CEO of the Syngenta Group, headquartered in Switzerland, explains why being Chinese-owned is good for the company.
HUG: ‘We see our strongest growth in foreign markets’
This content was published on
The two co-CEOs of Swiss biscuit maker HUG say the family-owned firm is not for sale. This is not stopping them from searching for acquisition targets.
This content was published on
Ypsomed CEO explains why US tariffs are not a worry and why he sees more growth from diabetes and obesity treatments such as Ozempic.
US consumers will pay price for tariff hike, warns top Swiss trader
This content was published on
Global competition is on the rise and some low value-added activities have already left Switzerland, warns Sébastien Landerretche.
Sandoz board chair ‘convinced that common sense will ultimately prevail’ on US pharma tariffs
This content was published on
In an exclusive interview with Swissinfo, Sandoz chair Gilbert Ghostine says he remains optimistic despite looming tariff hikes.
‘Our biggest challenge is to meet the demand for sustainable fuels’
This content was published on
New regulations are pushing airline carriers to gradually ditch oil for cleaner fuels. Synhelion, a Swiss start-up, is turning sunlight into fuel.
‘Hero is perceived as a Swiss brand … only in Switzerland’
This content was published on
Hero Group is known for its small jams found on breakfast tables in hotels. CEO Rob Versloot talks about being Swiss and downsizing its portfolio to remain competitive.
